Concepedia

Author

Kriangkrai Tawinprai

Chulabhorn HospitalORCID

Also Known As

K. Tawinprai, Kriangkrai Tawinprai, Tawinprai, Kriangkrai

37

Publications

191

Citations

9

H-Index

15

Concepts

All Affiliations

Chulabhorn Hospital
KT

About

Kriangkrai Tawinprai is an author at Chulabhorn Hospital specializing in epidemiology, vaccine safety, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

34

2

Public Health

2

2

34

3

Epidemiology

2

2

34

4

Immunology

1

1

19

5

Pediatric Epidemiology

1

1

15

Kriangkrai Tawinprai

×

8

Publications

119

Citations

8

H-Index

YearCitations

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines

Guy Cohen, Pawornrath Jungsomsri, Jirath Sangwongwanich,

Human Vaccines & Immunotherapeutics

2022

19

Efficacy of combination therapy of fluvoxamine and favipiravir vs favipiravir monotherapy to prevent severe COVID-19 among mild to moderate COVID-19 patients: Open-label randomized controlled trial (EFFaCo study)

Taweegrit Siripongboonsitti, Teerapat Ungtrakul, Kriangkrai Tawinprai,

International Journal of Infectious Diseases

2023

17

Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial

Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon,

Vaccine

2022

16

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Taweegrit Siripongboonsitti, Teerapat Ungtrakul, Kriangkrai Tawinprai,

Phytomedicine

2023

16

Safety after BBIBP-CorV (Sinopharm) COVID-19 Vaccine in Adolescents Aged 10–17 Years in Thailand

Saraiorn Thonginnetra, Kriangkrai Tawinprai, Krongkwan Niemsorn,

Vaccines

2022

15

Favipiravir treatment in non-severe COVID-19: promising results from multicenter propensity score-matched study (FAVICOV)

Taweegrit Siripongboonsitti, Marisa Muadchimkaew, Kriangkrai Tawinprai,

Scientific Reports

2023

14

Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population

Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon,

Human Vaccines & Immunotherapeutics

2022

12

Efficacy of combined COVID-19 convalescent plasma with oral RNA-dependent RNA polymerase inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial (PlasMab)

Taweegrit Siripongboonsitti, Nuttakant Nontawong, Kriangkrai Tawinprai,

Microbiology Spectrum

2023

10

Page 1